Pfizer unveils Assistance app 'Pfizer PAP India' for Indian patients

Patients can enroll in the program by uploading the required documents. The confirmation of enrolment into the program however is subject to the patient's medical eligibility, and verification of required documents. The key features of the app include:

 Easy: Helps quickly select PAP scheme options

 Simple: Enables hassle-free documentation

 Fast: Easy Fast-track enrolment

 Secure: Enhanced security

Last year, Pfizer launched its patient charter that defined how they interact and assist patients across the country. The charter focuses on making patient insights integral to their operational strategy, delivering easier and faster access to innovative therapies, and partnering with patient groups to support them. The company has launched multiple programs under this initiative over the last few months.

Speaking about the launch, Dr Rahul Bhargava (Director & HOD - Department of Hematology & BMT Fortis hospital Gurgaon) said, "We believe that access to medicines and medication adherence determines treatment effectiveness. These are some of the most useful interventions for improving health outcomes. However, this is possible only through regular patient monitoring and access to innovative medicines. Through PAP app, patients can now seamlessly navigate their health journey on a single platform where they are enrolled. We are certain that this endeavour will benefit the healthcare ecosystem as well as the patients."

PAP is executed by Tata 1 MG (MediAngels by TATA 1MG) on behalf of Pfizer India. "We are proud of our association with Pfizer which has gone a step further with the launch of Pfizer PAP India mobile application. For us at Tata 1 MG, Cancer Care is not just about providing services to patients but more importantly helping them navigate the journey better, with compassion and care. This app shall further enable patients to ease their access to medication and services through a self-serve platform. Now, patients will be able to avail all the applicable services directly and seamlessly by using the mobile application. Congratulations to the Pfizer and 1 MG teams for working collaboratively and continuing to innovate and enhance patient experience. This is yet another step closer to creating a better cancer journey for patients who need utmost care," said Prashant Tandon, Cofounder & CEO, Tata 1 MG.